Structures by: Wu S. X.

Total: 11

C37H31N3O4S

C37H31N3O4S

Gu, Bo-QiYang, Wu-LinWu, Shu-XiaoWang, Yan-BingDeng, Wei-Ping

Organic Chemistry Frontiers (2018) 5, 23 3430

a=13.6363(6)Å   b=8.5322(3)Å   c=15.2209(8)Å

α=90°   β=116.2050(10)°   γ=90°

C28H24AuF6N4P

C28H24AuF6N4P

Lu, WeiChan, Kaai TungWu, Shui-XingChen, YongChe, Chi-Ming

Chemical Science (2012) 3, 3 752

a=16.2749(9)Å   b=7.2655(4)Å   c=22.8836(13)Å

α=90.00°   β=91.975(2)°   γ=90.00°

C20H26N8O14Zn3

C20H26N8O14Zn3

Xu, Yan-HongLan, Ya-QianWu, Shui-XingShao, Kui-ZhanSu, Zhong-MinLiao, Yi

CrystEngComm (2009) 11, 8 1711

a=11.321(2)Å   b=11.321(2)Å   c=19.872(3)Å

α=90.000(5)°   β=90.000(5)°   γ=120.000(5)°

Regorafenib crystalline form I

C21H15ClF4N4O3

Sun, Meng-YingWu, Su-XiangZhou, Xin-BoGu, Jian-MingHu, Xiu-Rong

Acta Crystallographica Section C (2016) 72, 4 291-296

a=7.6972(4)Å   b=24.3703(12)Å   c=11.3580(7)Å

α=90.00°   β=93.545(2)°   γ=90.00°

Regorafenib monohydrate

C21H15ClF4N4O3,H2O

Sun, Meng-YingWu, Su-XiangZhou, Xin-BoGu, Jian-MingHu, Xiu-Rong

Acta Crystallographica Section C (2016) 72, 4 291-296

a=4.7783(2)Å   b=21.9538(9)Å   c=20.5581(8)Å

α=90.00°   β=92.3410(10)°   γ=90.00°

Vortioxetine

C18H22N2S

Zhou, Xin-BoGu, Jian-MingSun, Meng-YingHu, Xiu-RongWu, Su-Xiang

Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 8 883-885

a=7.6160(4)Å   b=8.3267(5)Å   c=13.9011(7)Å

α=84.999(2)°   β=77.6310(10)°   γ=74.347(2)°

1-{2-[(2,4-Dimethylphenyl)sulfanyl]phenyl}piperazine methanol monosolvate

C18H22N2S,CH4O

Zhou, Xin-BoGu, Jian-MingSun, Meng-YingHu, Xiu-RongWu, Su-Xiang

Acta crystallographica. Section E, Crystallographic communications (2015) 71, Pt 8 883-885

a=13.2100(7)Å   b=18.1500(9)Å   c=8.1746(4)Å

α=90.00°   β=104.378(2)°   γ=90.00°

Bis{tris[3-(2-pyridyl)pyrazole]manganese(II)} dodecamolybdosilicate hexahydrate

2(C24H21MnN92),Mo12O40Si4,6(H2O)

Niu, Bao-HuaLi, TaoXi, YanWu, Su-Xia

Acta Crystallographica Section E (2010) 66, 2 m201

a=18.907(4)Å   b=16.385(3)Å   c=27.552(6)Å

α=90.00°   β=105.09(3)°   γ=90.00°

Eprosartan mesylate

C23H25N2O4S,CH3O3S

Qian, Jing-JingHu, Xiu-RongGu, JianmingWu, Su-Xiang

Acta Crystallographica Section E (2011) 67, 4 o770-o771

a=8.6635(4)Å   b=12.6935(7)Å   c=13.6679(8)Å

α=112.700(2)°   β=101.3860(10)°   γ=96.7180(10)°

Quetiapine <i>N</i>-oxide--fumaric acid (2/1)

2(C21H25N3O3S),C4H4O4

Shen, JinQian, Jing-JingWu, Su-XiangGu, Jian-MingHu, Xiu-Rong

Acta Crystallographica Section E (2012) 68, 6 o1753-o1754

a=13.1299(9)Å   b=12.5047(8)Å   c=13.9950(9)Å

α=90.00°   β=101.59(2)°   γ=90.00°

7-[(1<i>S</i>,6<i>S</i>)-8-aza-2-azoniabicyclo[4.3.0]non-8-yl]-1-cyclopropyl-6- fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid chloride monohydrate

C21H25FN3O4,Cl,H2O

Qian, Jing-JingGu, Jian-MingShen, JinHu, Xiu-RongWu, Su-Xiang

Acta Crystallographica Section E (2011) 67, 10 o2773-o2774

a=6.7280(3)Å   b=10.6406(5)Å   c=15.3127(7)Å

α=91.7293(14)°   β=91.1313(13)°   γ=100.8823(13)°